Cresco Labs Inc (CRLBF)
1.95
-0.11
(-5.34%)
USD |
OTCM |
Apr 25, 15:59
Cresco Labs Price to Book Value: 1.310 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 24, 2024 | 1.384 |
April 23, 2024 | 1.350 |
April 22, 2024 | 1.330 |
April 19, 2024 | 1.344 |
April 18, 2024 | 1.411 |
April 17, 2024 | 1.471 |
April 16, 2024 | 1.377 |
April 15, 2024 | 1.344 |
April 12, 2024 | 1.344 |
April 11, 2024 | 1.444 |
April 10, 2024 | 1.458 |
April 09, 2024 | 1.538 |
April 08, 2024 | 1.545 |
April 05, 2024 | 1.505 |
April 04, 2024 | 1.391 |
April 03, 2024 | 1.512 |
April 02, 2024 | 1.464 |
April 01, 2024 | 1.505 |
March 28, 2024 | 1.391 |
March 27, 2024 | 1.498 |
March 26, 2024 | 1.372 |
March 25, 2024 | 1.347 |
March 22, 2024 | 1.451 |
March 21, 2024 | 1.478 |
March 20, 2024 | 1.391 |
Date | Value |
---|---|
March 19, 2024 | 1.377 |
March 18, 2024 | 1.424 |
March 15, 2024 | 1.270 |
March 14, 2024 | 1.134 |
March 13, 2024 | 1.202 |
March 12, 2024 | 1.048 |
March 11, 2024 | 1.021 |
March 08, 2024 | 1.055 |
March 07, 2024 | 1.034 |
March 06, 2024 | 1.055 |
March 05, 2024 | 1.135 |
March 04, 2024 | 1.088 |
March 01, 2024 | 1.149 |
February 29, 2024 | 1.162 |
February 28, 2024 | 1.189 |
February 27, 2024 | 1.196 |
February 26, 2024 | 1.283 |
February 23, 2024 | 1.344 |
February 22, 2024 | 1.243 |
February 21, 2024 | 1.135 |
February 20, 2024 | 1.169 |
February 16, 2024 | 1.164 |
February 15, 2024 | 1.243 |
February 14, 2024 | 1.216 |
February 13, 2024 | 1.169 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5588
Minimum
Aug 29 2023
12.27
Maximum
Apr 26 2019
3.039
Average
2.192
Median
Aug 06 2020
Price to Book Value Benchmarks
Flora Growth Corp | 2.536 |
Tilray Brands Inc | 0.4044 |
Clever Leaves Holdings Inc | 0.2812 |
Seelos Therapeutics Inc | -- |
Skye Bioscience Inc | -- |
Price to Book Value Related Metrics
PS Ratio | 0.8189 |
Price to Free Cash Flow | 926.98 |
Price | 1.95 |
Earnings Yield | -27.47% |
Market Cap | 662.43M |
Operating PE Ratio | 10.04 |